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We previously found that ethanol at millimolar level (1 mM) activates the expression of transcription factors 
with subsequent regulation of apoptotic genes in human hepatocellular carcinoma (HCC) HepG2 cells. However, 
the role of ethanol on the expression of genes implicated in transcriptional and translational processes remains 
unknown. Therefore, the aim of this study was to characterize the effect of low concentration of ethanol on gene 
expression profiling in HepG2 cells using cDNA microarrays with especial interest in genes with transcriptional 
and translational function. The gene expression pattern observed in the ethanol-treated HepG2 cells revealed a 
relatively similar pattern to that found in the untreated control cells. The pairwise comparison analysis 
demonstrated four significantly up-regulated (COBRA1, ITGB4, STAU2, and HMGN3) genes and one 
down-regulated (ANK3) gene. All these genes exert their function on transcriptional and translational processes 
and until now none of these genes have been associated with ethanol. This functional genomic analysis 
demonstrates the reported interaction between ethanol and ethanol-regulated genes. Moreover, it confirms the 
relationship between ethanol-regulated genes and various signaling pathways associated with ethanol-induced 
apoptosis. The data presented in this study represents an important contribution toward the understanding of 
the molecular mechanisms of ethanol at low concentration in HepG2 cells, a HCC-derived cell line. 
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1.  Introduction 
Studies using the human hepatocellular 
carcinoma (HCC) cell line HepG2 have demonstrated 
a specific gene expression pattern induced by ethanol 
different from that observed in normal livers and in 
livers with alcoholic liver disease [1, 2]. In vivo studies 
using animal models, including rats [3], mice [4], and 
baboons [5] as well as human liver samples obtained 
from patients with advanced alcoholic liver disease [5], 
revealed changes in the expression of genes coding for 
transcription factors, signaling molecules, stress 
response and ethanol metabolism [1]. These studies, 
however, have been performed using high 
concentrations of ethanol. 
Gene expression profiling using microarray 
technology allows the expression analysis of 
thousands of genes simultaneously [6-8]. This method 
is more informative than nonparallel studies on single 
genes [9, 10] providing information of networks of 
gene expression changes [11] [12]. The cDNA 
microarray technique has been used to evaluate the 
global gene expression in HCC as well as 
HCC-derived cell lines [13-16]. Moreover, HepG2 cells 
can be used to analyze the effect of ethanol on gene 
expression in HCC, based on the fact that HepG2 cells 
retain the genomic expression of HCC [15, 17, 18]. 
We previously reported the effect of ethanol at 
low concentration (namely 1 mM) on induction of 
different signaling pathways initiated through protein 
kinases phosphorylation with subsequent expression 
of transcription factors (AP1, Elk1, Stat1, SRF and 
NFκB) and expression of apoptotic genes (Fas receptor, 
Fas ligand, FADD and caspase 8) [19]. However, the 
effect of low concentration of ethanol on genes 
involved in transcriptional and translational processes 
remains to be characterized. Therefore, the aim of this 
study was to identify the effect of low concentration of 
ethanol (1 mM for 6 h) on gene expression, specifically 
from genes with transcriptional and translational 
function, in HepG2 cells compared to HepG2 cells not 
exposed to ethanol (control cells) using cDNA 
microarrays. We identified four significantly 
up-regulated (COBRA1, ITGB4, STAU2, and HMGN3) Int. J. Med. Sci. 2007, 4 
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and one down-regulated (ANK3) gene. Notably, none 
of these genes have been previously associated with 
ethanol with the exception of ITGB4 that has been 
found up-regulated with high concentrations of 
ethanol. 
This study represents an important advance in 
the characterization of the molecular mechanisms of 
low concentration of ethanol in HepG2 cells. 
Moreover, it constitutes a necessary step in the 
understanding of the molecular mechanisms involved 
in alcohol-induced effect in human hepatocellular 
carcinoma cells. In addition, this represents a novel 
approach for the identification of potential targets in 
the diagnosis and treatment of human hepatocellular 
carcinoma. 
2.  Materials and methods 
Cell culture and reagents 
Based on the reported alteration of gene 
expression of primary human hepatocytes in 
monolayer cultures [20] and the conserved gene 
expression profile in confluent HepG2 cells in vitro 
[21], the present study was performed only using 
HepG2 cells. 
HepG2 cells were seeded in 250 ml tissue culture 
flasks (Falcon, Heidelberg, Germany) at 1x105/ml 
concentration in 10 ml RPMI-1640 medium (Gibco, 
Eggersheim, Germany) supplemented with 10% fetal 
bovine serum (Boehringer Mannheim, Germany), 100 
U/ml penicillin and 100 µg/ml streptomycin (ICN, 
Meckenheim, Germany) at 37°C in a humidified 
atmosphere of 7.5% CO2. The cells were grown to 80% 
confluence. After 2 days of cell culture, the cells were 
harvested with 0.05% trypsin / 0.02% EDTA (Gibco) 
and seeded in 6-well plates (Falcon) at concentrations 
of 1x105/ml. Six sets of experiments were performed. 
Each set consist of two groups as follow: group 1, 
HepG2 treated cells with 1 mM ethanol for 6 h; and 
group 2, HepG2 cells without ethanol exposure used 
as a control. All chemicals were purchased from 
Sigma Aldrich (Seelze, Germany). 
Both the ethanol concentration at millimolar level 
(1 mM) and the exposition time (6 hr) were chosen 
based on the data obtained from previous studies 
[22-24]. They demonstrated that ethanol at low 
concentrations selectively induces apoptosis in HepG2 
cells without causing cell toxicity, which represents 
the hallmark of the ethanol effect when high 
concentrations are applied [25]. 
Total RNA extraction and microarray hybridization 
Total RNA was extracted using RNase kit 
(Qiagen, Hilden, Germany) and its quality was 
confirmed by electropherograms using a 2100 
BioAnalyzer (Agilent, Santa Clara, CA). Total RNA (5 
µg) were used for preparing biotinylated cRNA using 
GeneChip IVT Labeling Kit (Affymetrix, Santa Clara, 
CA). After confirmation of the quality of labeled 
cRNA using the Affymetrix Test 3 Array, cRNA was 
converted to cDNA using GeneChip One-Cycle cDNA 
Synthesis Kit (Affymetrix). Fifteen micrograms of 
labeled and fragmented cRNA were subsequently 
h y b r i d i z e d  t o  a  H u m a n  G e n o m e  U 1 3 3  p l u s  2 . 0  
microarray (Affymetrix). After the hybridization, the 
DNA microarrays were washed and stained on a 
Fluidics Station (Affymetrix) according to 
manufacturer’s instructions. Finally, the DNA 
microarrays were scanned with a GeneChip Scanner 
3000 (Affymetrix). 
DNA microarray analysis 
Data analyses were performed using the 
GeneChip Expression Analysis Software (version 3.2, 
Affymetrix). First, single array analysis was 
performed [11] to calculate for each gene a signal, 
which represents a relative measure of the abundance 
of the transcript with a detection p-value. To evaluate 
the gene expression profile between group 1 
(ethanol-treated) and group 2 (control) a hierarchical 
cluster analysis was performed [26-28]. 
For a quantitative estimation of the change in 
gene expression between both groups a pairwise 
comparison analysis was performed. For that purpose 
a signal log ratio (SLR; basis 2) using a one-step 
Tukey's biweight method was calculated [29] [30]. 
Genes with a SRL > 1 or <-1 in at least 3 experiments 
(50%) were selected for further analyses. 
Quantitative real-time PCR Analysis 
Quantitative real-time PCR was used to validate 
the effect of ethanol on gene expression. Total RNA 
was isolated from HepG2 cells using RNAsy kit 
(Qiagen) and RNA quality was evaluated using RNA 
6000 Nano Chip Kit and Bioanalyzer 2100 (Agilent, 
Böbligen, Germany). Real-time PCR was performed 
using the QuantiTect SYBR green RT-PCR kit (Qiagen). 
Specific primers for each selected gene were used. A 
quantitative real-time PCR determination using the 
Optical System Software (iQ5 version 1.0) provided 
with the BioRad iQ5 cycler (BioRad, Munich, Ger-
many) was performed. The following primers were 
used:  ITGB4 forward, 
5’-CCTGTACCCGTATTGCGACT-3’;  ITGB4 reverse 
5’-AGGCCATAGCAGACCTCGTA-3’;  COBRA1 for-
ward 5’-TGAAGGAGACCCTGACCAAC-3’; COBRA1 
reverse 5’-ATCGAATACCGACTGGTGGA-3’; ANK3 
forward 5’-GGAGCATCAGTTTGACAGCA-3’; ANK3 
reverse 5’-TTCCACCTTCAGGACCAATC-3’; STAU2 
forward 5'-CCGTGAGGGATACAGCAGTT-3'; STAU2 
reverse 5’-GCCCATTCAGTTCCACAGTT-3’; HMGN3 
forward 5’-TGCCAGATTGTCAGCGAAAC-3; 
HMGN3 reverse 
5’-TGCTCCACCAAAACCTGAACCAAAC-3. All 
primers were synthesized by MWG Biotech AG 
(Ebersberg, Germany). Samples were prepared in 
triplicate and real time PCR measurement for each 
sample was done in duplicate. The expression level of 
each gene was normalized using the control group 
(group 2) and an induction ratio (treated/control) was 
obtained. The average of duplicate real time PCR 
measurements was used to calculate the mean induc-
tion ratio ± SD for each gene. Int. J. Med. Sci. 2007, 4 
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Statistical analysis 
Data are expressed as mean values ± standard 
deviation (SD). Results from HepG2 cells treated with 
1mM concentration of ethanol (group 1) were 
compared to non-treated HepG2 cells (control cells, 
group 2) using Student's t-test. Statistical significance 
was assumed at p level <0.05 level. SigmaPlot 
software version 8.02 (Systat Software, Erkrath, 
Germany) was used for statistical analysis.   
Statistical analyses of microarray data were 
performed using a permutation procedure [31, 32] as 
well as a non-parametric method [33]. These two 
methods allowed us to analyze whether a gene had no 
expression change (null hypothesis) or whether it did 
(alternative hypothesis). Based on the expression 
measurements, a decision is made either for the null 
or the alternative hypothesis. In order to keep the 
number of false positive decisions small, the two 
testing procedures were set up to control for the 
family-wise error rate (FWER), which is the 
probability of having more than one false positive 
decision among all n tests. In particular, the testing 
procedures guaranteed an FWER ≤ 0.05 [34]. 
3.  Results 
Low concentration of ethanol selectively expresses 
genes involved in transcriptional and translational 
processes  
Figure 1 shows the hierarchical gene expression 
profile of 1 mM ethanol concentration treated HepG2 
cells (group 1) and control cells (HepG2 cells without 
treatment; group 2) exposed for a 6 h period. Data are 
presented as a median of the signal obtained from the 
six different microarrays for each group (n=6). Each 
single array had good quality control and showed a 
normal distribution and linearity. The red zones 
indicate up-regulated gene expression and the green 
zones indicate down-regulated gene expression. The 
gene expression pattern between the two groups 
revealed a relatively similar pattern, suggesting that 
only few genes are changed with exposure of a low 
concentration of ethanol. The pairwise comparison 
analysis demonstrated the selective effect of ethanol 
on fives genes involved in transcriptional and 
translational processes. As shown in Table 1, the 
up-regulated genes were COBRA1,  ITGB4,  STAU2, 
and HMGN3 with a SLR of 3.30, 2.61, 1.68 and 1.52, 
respectively.  ANK3 was the only significantly 
down-regulated gene with a SLR of -5.02. 
Figure 1. Hierarchical clustering analysis of gene expression 
profile in ethanol-treated HepG2 cells (1 mM ethanol for 6 h, 
Group 1) compared to control HepG2 cells (Group 2). Each 
row represents the mean of signal log ratios (n=6 arrays each 
group) using a color-code scale. Red represents expression 
greater than reference, green is less than reference, and gray 
is missing or excluded data.  
 
 
Table 1. Ethanol-regulated genes obtained from the pairwise comparison analysis between ethanol-treated (1 mM for 6 h) and 
control HepG2 cells. 
Probeset Gene 
symbol 
Gene title  Signal Log 
Ratio 
Function Gene  ID 
202757_at  COBRA1  cofactor of BRCA1  ▲ 3.30  regulation of transcription  NM_015456 
204990_s_at  ITGB4  integrin, beta 4  ▲ 2.61  protein binding  NM_000213 
204226_at  STAU2  staufen, RNA binding protein, homolog 2 
(Drosophila) 
▲ 1.68  double-stranded RNA 
binding 
NM_014393 
209377_s_at  HMGN3  high mobility group nucleosomal binding 
domain 3 
▲ 1.52  DNA binding  NM_004242 
206385_s_at  ANK3  ankyrin 3, node of Ranvier (ankyrin G)  ▼ 5.02  protein binding  NM_001149 
▲- increased 
▼- decreased 
Validation of microarray results by quantitative real 
time RT-PCR analyses 
In order to validate the observed expression on 
the ethanol-regulated genes (COBRA1, ITGB4, STAU2, 
HMNG3, and ANK3), we performed quantitative real 
time RT-PCR in HepG2 cells treated with ethanol. The 
primers used showed a linear specificity. The results 
were normalized to control mRNA level (i.e. HepG2 
cells without ethanol treatment). We did not use 
housekeeping genes, such as GADPH, actin or LDHA, 
because ethanol also alters the expression of these 
genes (data not shown). The relative mRNA level for 
each gene is shown in Figure 2. The obtained mRNA Int. J. Med. Sci. 2007, 4 
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level for COBRA1, ITGB4, STAU2, and HMGN3 was 
38.0, 22.7, 5.5, and 3.8, respectively. In the case of 
ANK3, the real time RT-PCR did not give any 
transcript with two different primers. This might be 
due to the strong down-regulation of ANK3 observed 
with ethanol treatment. The results from 
semi-quantitative RT-PCR quantified and confirmed 
the findings of the microarray analysis on gene 
expression in response to ethanol. 
Figure 2. Validation of ethanol-regulated genes by real time 
RT-PCR.  mRNA levels of ethanol-regulated genes 
determined by real time RT-PCR. Induction ratios of each 
gene (fold change) by ethanol were calculated using 
expression level, normalized to the level of the control group 
(HepG2 without ethanol treatment). Experiments were done 
in triplicate (n=3) and error bars indicate standard deviation 
among the triplicate samples. 
 
 
Gene ontology analysis 
Once the ethanol-regulated genes were validated, 
we analyzed further their implication in different 
biological processes. For this purpose, the 
ethanol-regulated genes were functionally clustered 
into specific biological processes from the 
classification systems of the gene ontology annotation 
[35]. The gene ontology analysis of the identified 
genes is shown in Table 2. The biological processes 
associated with the up-regulated genes in the 
ethanol-treated HepG2 cells were as follow: regulation 
of transcription for COBRA1; cell communication, cell 
adhesion, cell-matrix adhesion, integrin-mediated 
signaling, and development for ITGB4; transport for 
STAU2; and an unknown biological process for 
HMGN3. The biological processes in which ANK3, the 
down-regulated gene, was involved were protein 
targeting, cytoskeletal anchoring and signal 
transduction. 
Additionally, we evaluated the functional 
pathways in which the ethanol-regulated genes were 
involved using KEGG (Kyoto Encyclopedia of Genes 
and Genomes) [36] and GenMAPP (Gene Microarray 
Pathway Profiler) [37] analysis. As shown in Table 2, 
only ITGB4 was found to be involved in intracellular 
pathways including cell communication, focal 
adhesion, extra cellular matrix-receptor interaction 
and regulation of cytoskeleton. These data suggest an 
important role of integrin in the molecular 
mechanisms of ethanol effects in HepG2 cells. The 
other ethanol-regulated genes were not found to be 
associated with any specific pathway. 
Table 2. Gene ontology in terms of biological processes of the ethanol-regulated genes in HepG2 cells. 
Gene symbol  Gene ontology (GO) biological process  KEGG/ GenMAPP Pathway 
GO:0006350 transcription  --  COBRA1 
GO:0006355  regulation of transcription, DNA-dependent  -- 
GO:0007154 cell  communication hsa01430  Cell Communication 
GO:0007155 cell  adhesion hsa04510  Focal adhesion 
GO:0007160 cell-matrix  adhesion hsa04512  ECM-receptor interaction 
GO:0007229  integrin-mediated signaling pathway  hsa04810  Regulation of actin cytoskeleton 
ITGB4 
GO:0007275 development  -- 
STAU2  GO:0006810 transport  -- 
HMGN3  GO:0008150  biological process unknown  -- 
GO:0006605 protein  targeting 
GO:0007016 cytoskeletal  anchoring 
ANK3 
GO:0007165 signal  transduction 
-- 
Functional genomics analysis of ethanol-regulated 
genes 
In an effort to find gene regulatory networks 
associated with low concentration of ethanol, we 
analyzed the interaction between the 
ethanol-regulated genes studied using Pathway 
Architect software (Stratagene). Figure 3A shows the 
reported interactions of each of these genes. ITGB4 
and  ANK3 are associated with different targets, 
including small molecules, genes and proteins. In 
contrast,  COBRA1,  STAU2 and HMGN3 are only 
associated with very few targets. Figure 3B shows the 
reported interaction network between ethanol and the 
five ethanol-regulated genes of interest. Of note, 
ITGB4, COBRA1 and  ANK3 are indirectly associated 
with ethanol through phosphatidylinositol, GTP and 
chloride, respectively. There are until now no reported 
interactions observed for STAU2 and HMGN3. Figure 
3C shows the interaction of ethanol with similar 
signaling pathways, in which ethanol-regulated genes 
are also involved. Such pathways include ERK-PI3K, 
AKT, NO, cAMP-PKA, PTEN, G-Protein-MAPK, NGF, 
and PDGF signaling. This finding corroborates the 
interaction observed between various intracellular 
signaling pathways and apoptosis induced by 1mM 
concentration of ethanol in HepG2 cells [19]. Int. J. Med. Sci. 2007, 4 
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Figure 3. Functional genomics of low concentrations of ethanol in HepG2 cells.  (A) Reported interactions of each 
ethanol-regulated gene studied. (B) Indirect interaction of ITGB4, COBRA1 and ANK3 with ethanol, as reported in the 
literature. (C) Interaction of ethanol with similar signaling pathways in which COBRA1, ITGB4, STAU2, HMGN3, and ANK3 
are also involved. 
 Int. J. Med. Sci. 2007, 4 
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4.  Discussion 
The gene expression profile of HepG2 cells 
exposed to a low concentration of ethanol (equivalent 
to 1mM) demonstrates a totally different pattern to 
that observed with exposure to ethanol at high 
concentrations. Ethanol at high concentration 
modulates multiple functional interactions explaining 
its toxic effect in the liver. In vitro studies using HepG2 
cells over-expressing CYP2E1, an ethanol 
metabolizing enzyme, demonstrated that high 
concentrations of ethanol (100 mM) induced the 
expression of genes involved in the metabolism of 
ethanol [16]. In addition, the metabolism of ethanol 
results in an increased production of toxic metabolites 
such as free radicals. These metabolites have an effect 
on gene expression [30]. In contrast, our findings 
suggest that 1mM concentration of ethanol regulates 
genes that are not directly involved in ethanol 
metabolism. Specifically, the gene expression profile 
induced by this low concentration of ethanol suggests 
a balance between biological processes, as shown by 
the pattern of up- and down-regulated genes we 
observed. Among the ethanol-regulated genes we 
found, only ITGB4 has been reported in association 
with ethanol. Chronic ethanol consumption increases 
the expression of integrins but impairs hepatocyte 
attachment and spreading on various extracellular 
matrix substrates [38]. Int. J. Med. Sci. 2007, 4 
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Importantly, low concentration of ethanol exerts 
its effect through induction of transcription factors 
(AP1, Elk1, Stat1, SRF and NFκB) and expression of 
apoptotic genes (Fas receptor, Fas ligand, FADD and 
caspase 8) [19]. In addition, as confirmed by the 
functional genomics analysis presented in this study, 
ethanol at low concentration (1 mM) also regulates the 
expression of genes involved in transcriptional and 
translational processes. 
Integrins act as signal transducing molecules 
trough mitogen-activated protein (MAP) kinase like 
extracellular-regulated kinase 1 (ERK1) and ERK2 . 
Moreover, the role of MAP kinases on the modulation 
of gene expression depends on integrin engagement 
rather than simply on cell attachment . The increased 
expression of ITGB4 induced by 1 mM ethanol, we 
found, suggests a regulatory mechanism on the signal 
transduction pathways activated through ethanol. 
The central role of ethanol on transcriptional 
regulation processes could be explained by the 
increased expression of COBRA1. The COBRA1 
protein has been shown to be an integral subunit of 
the human negative transcription elongation factor . In 
addition, over-expression of COBRA1 represses the 
transcriptional activity of activating protein-1 (AP1) 
transcription factor [40]. Since ethanol-induced 
phosphorylation of protein kinases leads to an 
increased expression of transcription factors including 
AP1 [19], the effect of low concentration of ethanol on 
COBRA1 suggests a regulatory effect on transcription. 
Our data also demonstrated an increased expression 
of HMGN3. HMGN nuclear proteins bind specifically 
to nucleosomes, reduce the compactness of the 
chromatin fiber, and enhance transcription from 
chromatin templates . Interestingly, HMGN3 has been 
found to be associated with resistance against 
anticancer drugs including vinblastine, topotecan, 
paclitaxel and doxorubincin in human hepatocellular 
carcinoma derived cell lines . The resistance against 
anticancer drugs has been associated with the 
expression of transcription factors, such as NFκB and 
AP1 . These transcription factors are significantly 
over-expressed in ethanol-treated HepG2 cells, 
suggesting a role of ethanol-induced regulation on 
genes involved in transcriptional processes that could 
be applied to develop new strategies for the treatment 
of human hepatocellular carcinoma. 
Our data also confirms the effect of low 
concentration of ethanol on genes involved in 
translational processes such as STAU2, a protein that 
facilitates the initiation of translation . Based on the 
increased expression of staufen proteins associated 
with Hepatitis C virus (HCV) infection , a leading 
cause of severe hepatitis that often develops into liver 
cirrhosis and hepatocellular carcinoma, the selective 
regulation of ethanol on STAU2 may represent an 
important target for future studies addressing the 
molecular mechanisms of ethanol on human 
hepatocellular carcinoma and requires further 
investigation. 
Notably, the down-regulatory effect of 1mM 
ethanol concentration on ANK3 we observed, 
provides a potential therapeutic approach when 
considering the reported high expression of the 
ankyrin-repeat oncoprotein (gankyrin) in human 
hepatocellular carcinoma . Gankyrin binds to the 
cell-cycle regulator CDK4 and the S6b ATPase subunit 
of the regulatory component of the proteasome. 
Based on the conserved gene expression profile 
in confluent HepG2 cells in vitro [21], the regulation of 
genes involved in transcriptional and translational 
processes we found suggests a potential therapeutic 
effect of ethanol at low concentration for the treatment 
of human hepatocellular carcinoma. However, it 
should be only considered for direct application into 
the tumor, known as percutaneous ethanol injection. 
The systemic application or the ingestion of ethanol 
induces a completely different pattern due to the 
reported ethanol-induced expression and activation of 
cytokines and chemokines in monocytes and 
macrophages (including Kupffer cells) [41, 42], and 
ethanol-induced mucosal injury in the upper 
gastrointestinal tract leading to increase in the 
permeability of the gut mucosa to endotoxins [43, 44]. 
These factors are involved in ethanol-induced liver 
damage. Thus, the direct injection of low 
concentration of ethanol for the treatment of 
hepatocellular carcinoma represents a promising 
alternative to improve the limitation of percutaneous 
ethanol injection, which is only indicated for small 
and single tumors [45, 46]. 
In conclusion, the functional genomics analysis 
presented in this investigation confirms the effect of 
ethanol at low concentration (1 mM) on the expression 
of genes involved in transcriptional and translational 
processes that are also associated with human 
hepatocellular carcinoma. These findings represent an 
important contribution toward the understanding of 
the molecular mechanisms of ethanol at low 
concentration in HepG2 cells, and a novel approach 
for the identification of potential targets in the 
diagnosis and treatment of human hepatocellular 
carcinoma. 
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